Filing status
- Accounts due
- 31 January 2027
- Last accounts
- 30 April 2025
- Conf. stmt due
- 10 April 2027
- Last conf. stmt
- 27 March 2026
Champions Oncology UK Limited
- Incorporated
- 27 March 2009 (17 years)
- Previously known as
- Champions Biotechnology UK Limited (until 25 July 2012)
- Industry
- Research and experimental development on biotechnology (72110)
- Directors
- Joel Ackerman
- Owned by
- Champions Oncology, Inc.
- Accounts type
- Medium
- Region
- Greater London
- Address
- Suite 17th Floor50 BroadwayLondonSW1H 0BL
Officers 3 active
Officer details are public data from the Companies House register.
Ackerman, Joel
Director · Appointed 6 April 2011
American
Born August 1965 (61)
Corporate Secretary · Appointed 27 March 2010
Director · Appointed 8 February 2010
American
Born June 1960 (66)
Officer history (3 former)
13 January 2012
Resigned Malchi, Guy as Director
6 April 2011
Appointed Ackerman, Joel as Director
6 April 2011
Resigned Schonau, Mark as Director
27 March 2010
8 February 2010
8 February 2010
Resigned Burkett, Douglas as Director
27 March 2009
Appointed Burkett, Douglas as Director
27 March 2009
Appointed Schonau, Mark as Director
27 March 2009
Appointed Malchi, Guy as Director
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Champions Oncology, Inc.
Corporate entity · Notified 6 April 2016
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Corporation
Reg. no. 2063377
Financials
Balance sheet as at 30 April 2025 · medium accounts
- Cash
- £66,122
- Turnover
- £1,783,479
- Profit Before Tax
- £0
- Current Ratio
- 0.2x
- Profit Margin
- 0%
Trend
Turnover
Balance sheet detail
| 2025 | 2024 | 2020 | |
|---|---|---|---|
| Current Assets | £101,036 | £77,256 | USD 20,840 |
| Debtors | £34,914 | £14,790 | USD 4,255 |
| Cash | £66,122 | £62,466 | USD 16,585 |
| Creditors (< 1 year) | £671,549 | £659,401 | USD 628,465 |
| Net Current Assets | (£570,513) | (£582,145) | (USD 607,625) |
| Shareholder Funds | (£570,513) | (£582,145) | (USD 607,625) |
| Turnover | £1,783,479 | £2,078,892 | USD 928,527 |
| Cost of Sales | £305,773 | £369,118 | USD 86,372 |
| Gross Profit | £1,477,706 | £1,709,774 | USD 842,155 |
| Admin Expenses | £292,793 | £673,491 | USD 57,046 |
| Operating Profit | (£64) | ||
| Profit Before Tax | £0 | £0 | USD 0 |
| Tax | £0 | £0 | USD 0 |
| Profit for Period | £0 | £0 | USD 0 |
Filings 62
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 18 May 2026 | Accounts for a medium company | 30 April 2025 | ||
| 28 April 2026 | Confirmation statement with no updates | 27 March 2026 | ||
| 27 April 2026 | Secretary's details changed | |||
| 23 April 2026 | Director's details changed | |||
| 23 April 2026 | Director's details changed |
Some other companies at this address
Other companies in this industry
Oxford
Sandwich
Newcastle Upon Tyne
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →